Alerts will be sent to your verified email
Verify Email
TLL
|
Trident Lifeline
|
Medico Remedies
|
Kimia Biosciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Unclassified
|
|||
|
Advertisement Spend as a % of Total Sales
|
0.37 % | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
35.94 % | 11.79 % | -352.38 % |
|
5yr average Equity Multiplier
|
1.91 | 2.18 | 65.1 |
|
5yr Average Asset Turnover Ratio
|
0.9 | 1.48 | 1.17 |
|
5yr Avg Net Profit Margin
|
17.11 % | 3.76 % | -2.03 % |
|
Price to Book
|
5.59 | 5.59 | 0.0 |
|
P/E
|
27.41 | 34.54 | 39.76 |
|
5yr Avg Cash Conversion Cycle
|
94.4 Days | 34.15 Days | 28.76 Days |
|
Inventory Days
|
68.55 Days | 52.67 Days | 94.07 Days |
|
Days Receivable
|
104.41 Days | 107.96 Days | 101.18 Days |
|
Days Payable
|
126.58 Days | 136.18 Days | 144.79 Days |
|
5yr Average Interest Coverage Ratio
|
17.94 | 9.64 | 0.28 |
|
5yr Avg ROCE
|
29.15 % | 17.25 % | -0.98 % |
|
5yr Avg Operating Profit Margin
|
16.89 % | 5.84 % | 1.32 % |
|
5 yr average Debt to Equity
|
0.34 | 0.3 | 29.7 |
|
5yr CAGR Net Profit
|
9.93 % | 38.44 % | n/a |
|
5yr Average Return on Assets
|
15.87 % | 5.66 % | -2.12 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
63.04 % | 63.79 % | 74.94 % |
|
Share Pledged by Promoters
|
3.46 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-6.53 % | -9.55 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Trident Lifeline
|
Medico Remedies
|
Kimia Biosciences
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Segment Break-Up
|
Segment Break-Up
|
Segment Break-Up
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|